TipRanks
Go Ultimate55% OFF

Clal Biotech (CBI) Income Statement

Clal Biotech Income Statement

Last quarter (Q2 2026), Clal Biotech's total revenue was $638.50K. In Q2, Clal Biotech's net income was $-2.94M. See Clal Biotech’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 835.00K$ 433.00K$ 104.00K$ 370.00K$ 224.00K
$ 364.00K$ -183.00K$ 104.00K$ 370.00K$ 224.00K
$ 18.78M$ 6.34M$ 10.29M$ 12.27M$ 77.47M
Depreciation and Amortization$ 216.00K$ 283.00K$ 526.00K$ 17.64M$ 22.51M
$ -19.83M$ -6.34M$ -24.02M$ 64.22M$ -55.08M
$ -18.41M$ -6.34M$ -10.18M$ -27.42M$ -77.59M
$ -1.76M$ -68.73M$ -17.91M$ -13.61M$ 11.00M
$ -20.17M$ -75.07M$ -28.09M$ -41.02M$ -66.59M
$ -13.32M$ -62.46M$ -31.05M$ -61.74M$ -89.58M
Per Share Metrics
Basic EPS$ -0.08$ -0.40$ -0.20$ -0.39$ -0.57
Diluted EPS$ -0.08$ -0.40$ -0.20$ -0.39$ -0.57
Weighted Average Shares Outstanding156.85M158.44M156.85M156.85M158.44M
Weighted Average Shares Outstanding (Diluted)156.85M158.44M156.85M156.85M158.44M

Currency in ILS

Clal Biotech Earnings and Revenue History

-300M-150M0150M-50000 %0 %50000 %100000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin